First Header Logo Second Header Logo

Timothy Pardee

Concepts (244)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Acute
24
2020
200
6.820
Why?
Antineoplastic Agents
15
2020
607
3.190
Why?
Antineoplastic Combined Chemotherapy Protocols
11
2020
461
2.760
Why?
Salvage Therapy
4
2019
134
1.410
Why?
Drug Resistance, Neoplasm
7
2019
104
1.340
Why?
Hematopoietic Stem Cell Transplantation
2
2020
94
1.160
Why?
Cytarabine
7
2020
55
1.150
Why?
Apoptosis
8
2019
354
1.090
Why?
Fluorodeoxyuridylate
3
2016
23
1.050
Why?
Neoplasms
3
2018
692
1.050
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2017
44
1.040
Why?
Sulfides
6
2019
27
1.030
Why?
Caprylates
6
2019
28
1.030
Why?
Enzyme Inhibitors
3
2020
165
1.020
Why?
Tumor Suppressor Protein p53
4
2014
79
0.920
Why?
Bone Marrow
3
2020
70
0.880
Why?
Mitochondria
4
2019
186
0.830
Why?
Cell Membrane
1
2020
96
0.690
Why?
Aged
22
2020
10340
0.660
Why?
Humans
36
2020
32024
0.650
Why?
Mice, Inbred C57BL
7
2017
766
0.640
Why?
Middle Aged
21
2020
11868
0.620
Why?
Body Composition
1
2020
396
0.610
Why?
Resuscitation Orders
1
2017
13
0.600
Why?
Glycerophosphates
1
2017
4
0.600
Why?
Myelodysplastic Syndromes
2
2014
24
0.590
Why?
Neoplasm Recurrence, Local
2
2019
370
0.580
Why?
Deoxycytidine
1
2017
68
0.580
Why?
Intensive Care Units
1
2017
110
0.560
Why?
Neoplasm Proteins
2
2014
148
0.560
Why?
fms-Like Tyrosine Kinase 3
2
2019
17
0.560
Why?
Leukemia
2
2014
40
0.550
Why?
Nucleosides
1
2016
10
0.540
Why?
Female
23
2020
19953
0.530
Why?
Survival Rate
7
2020
885
0.520
Why?
DNA Topoisomerases, Type I
2
2012
9
0.520
Why?
Thymidylate Synthase
2
2012
14
0.520
Why?
Animals
12
2018
7466
0.510
Why?
Mice
9
2018
2475
0.500
Why?
Cytogenetics
1
2015
7
0.500
Why?
Male
22
2020
19195
0.500
Why?
Fas Ligand Protein
1
2014
7
0.500
Why?
Membrane Microdomains
1
2014
21
0.490
Why?
Hydroxamic Acids
1
2014
21
0.490
Why?
Prognosis
9
2020
1505
0.480
Why?
Lipids
1
2016
229
0.480
Why?
Hematologic Neoplasms
1
2014
35
0.470
Why?
Pyrimidines
1
2014
65
0.470
Why?
DNA Damage
4
2017
98
0.460
Why?
Azacitidine
1
2013
28
0.460
Why?
Mitoxantrone
3
2019
19
0.460
Why?
Remission Induction
5
2020
84
0.450
Why?
Aged, 80 and over
9
2020
4000
0.440
Why?
Adult
13
2020
9366
0.430
Why?
Oncogene Proteins
1
2012
6
0.420
Why?
Gene Expression Regulation, Leukemic
1
2012
24
0.420
Why?
Treatment Outcome
8
2020
3317
0.420
Why?
Apoptosis Regulatory Proteins
1
2012
41
0.420
Why?
DNA Methylation
1
2013
140
0.420
Why?
Proto-Oncogene Proteins
1
2012
85
0.410
Why?
Tumor Suppressor Proteins
1
2012
71
0.410
Why?
Disease Models, Animal
5
2014
1017
0.390
Why?
Tandem Repeat Sequences
1
2011
6
0.380
Why?
Leukemia, Myeloid
1
2011
24
0.380
Why?
Membrane Proteins
1
2012
257
0.370
Why?
Cell Line, Tumor
5
2017
725
0.370
Why?
Aniline Compounds
2
2020
18
0.360
Why?
Geriatric Assessment
4
2020
391
0.360
Why?
Prospective Studies
7
2020
2283
0.350
Why?
Doxorubicin
3
2017
82
0.340
Why?
Recurrence
3
2019
265
0.310
Why?
Mutation
2
2020
488
0.300
Why?
Follow-Up Studies
4
2020
2280
0.290
Why?
Survival Analysis
4
2020
488
0.280
Why?
Pancreatic Neoplasms
2
2019
140
0.280
Why?
Retrospective Studies
6
2018
3523
0.280
Why?
Adenocarcinoma
2
2019
311
0.260
Why?
Neoplasm Transplantation
2
2017
73
0.250
Why?
Neoplasm Staging
2
2018
456
0.250
Why?
Age Factors
4
2018
1194
0.240
Why?
Drug Administration Schedule
2
2015
273
0.230
Why?
Mice, Transgenic
2
2017
261
0.230
Why?
RNA Polymerase II
1
2003
1
0.220
Why?
Transcriptional Elongation Factors
1
2003
1
0.220
Why?
Genes, Regulator
1
2003
5
0.220
Why?
Guanosine Triphosphate
1
2003
8
0.220
Why?
International Agencies
2
2019
10
0.220
Why?
Comorbidity
5
2018
569
0.210
Why?
Transcription, Genetic
1
2003
137
0.210
Why?
Electron Transport
2
2019
16
0.200
Why?
RNA, Messenger
1
2003
508
0.190
Why?
Hyperglycemia
2
2018
85
0.190
Why?
Isocitrate Dehydrogenase
1
2020
7
0.180
Why?
Benzimidazoles
1
2020
28
0.180
Why?
Pyrazines
1
2019
13
0.180
Why?
Young Adult
2
2018
2615
0.170
Why?
Proto-Oncogene Proteins c-bcl-2
1
2019
34
0.170
Why?
Heme
1
2019
61
0.160
Why?
Cell Proliferation
2
2018
599
0.160
Why?
HSP90 Heat-Shock Proteins
1
2018
9
0.160
Why?
Citric Acid Cycle
1
2018
11
0.160
Why?
Combined Modality Therapy
1
2020
565
0.160
Why?
Protein Biosynthesis
1
2018
40
0.160
Why?
Cell Respiration
1
2018
22
0.160
Why?
Retreatment
1
2018
41
0.150
Why?
HL-60 Cells
2
2014
14
0.150
Why?
Proportional Hazards Models
3
2015
757
0.150
Why?
Philadelphia Chromosome
1
2017
4
0.150
Why?
Protein Kinase C
1
2017
31
0.150
Why?
Tumor Burden
1
2017
60
0.150
Why?
Hematologic Diseases
1
2017
24
0.150
Why?
Drug Screening Assays, Antitumor
1
2017
58
0.150
Why?
Oxygen Consumption
1
2018
154
0.140
Why?
Patient Transfer
1
2017
44
0.140
Why?
Splenomegaly
1
2016
7
0.140
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
2016
9
0.140
Why?
Cell Line
1
2018
435
0.140
Why?
Biopsy
1
2018
260
0.140
Why?
Cosmic Radiation
1
2016
14
0.140
Why?
Random Allocation
1
2017
220
0.140
Why?
Small Cell Lung Carcinoma
1
2016
17
0.140
Why?
DNA, Neoplasm
2
2013
55
0.140
Why?
Radiation Injuries
1
2016
72
0.140
Why?
Biological Availability
1
2016
21
0.130
Why?
Tumor Cells, Cultured
2
2016
168
0.130
Why?
Blood Glucose
1
2018
492
0.130
Why?
Asparaginase
1
2015
5
0.130
Why?
Depression
2
2016
442
0.130
Why?
Dose-Response Relationship, Drug
1
2017
629
0.130
Why?
Activities of Daily Living
1
2016
259
0.130
Why?
Transplantation, Homologous
1
2015
151
0.120
Why?
Tumor Stem Cell Assay
1
2014
12
0.120
Why?
Ribonucleotide Reductases
1
2014
6
0.120
Why?
Cognition
2
2016
553
0.120
Why?
Drug Evaluation, Preclinical
1
2014
62
0.120
Why?
Lung
1
2016
255
0.120
Why?
Polypharmacy
1
2014
17
0.120
Why?
Oligonucleotides
1
2014
30
0.120
Why?
Hematopoietic Stem Cells
1
2014
100
0.120
Why?
Mice, Inbred BALB C
1
2014
168
0.120
Why?
Myeloid-Lymphoid Leukemia Protein
2
2011
8
0.120
Why?
Drug Evaluation
1
2013
14
0.120
Why?
Stem Cells
1
2016
313
0.120
Why?
Occupational Exposure
1
2016
233
0.110
Why?
Positron-Emission Tomography
1
2014
163
0.110
Why?
Databases, Factual
1
2015
355
0.110
Why?
Hospitalization
2
2018
470
0.110
Why?
Gene Fusion
1
2012
2
0.110
Why?
Nuclear Pore Complex Proteins
1
2012
5
0.110
Why?
Translocation, Genetic
1
2012
20
0.110
Why?
Phenotype
1
2015
639
0.110
Why?
Proto-Oncogene Proteins c-mdm2
1
2012
8
0.110
Why?
DNA Replication
1
2012
34
0.110
Why?
Homeodomain Proteins
1
2012
51
0.100
Why?
Antimetabolites, Antineoplastic
1
2012
49
0.100
Why?
Clinical Trials as Topic
1
2014
300
0.100
Why?
Lung Neoplasms
1
2016
409
0.100
Why?
Trans-Activators
1
2012
46
0.100
Why?
Histones
1
2012
53
0.100
Why?
Inhibitory Concentration 50
1
2012
22
0.100
Why?
Substrate Specificity
1
2012
87
0.100
Why?
Xenograft Model Antitumor Assays
1
2012
114
0.100
Why?
Transcription Factors
1
2012
180
0.100
Why?
Genetic Predisposition to Disease
1
2015
835
0.100
Why?
Benzenesulfonates
1
2011
3
0.100
Why?
Gene Duplication
1
2011
5
0.100
Why?
Phenylurea Compounds
1
2011
10
0.100
Why?
Niacinamide
1
2011
8
0.100
Why?
Signal Transduction
1
2014
687
0.090
Why?
Pyridines
1
2011
76
0.090
Why?
RNA Interference
1
2011
76
0.090
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2011
261
0.090
Why?
Blotting, Western
1
2011
292
0.090
Why?
Acute Disease
1
2011
254
0.090
Why?
Risk Factors
2
2015
3869
0.090
Why?
Tomography, X-Ray Computed
1
2014
918
0.080
Why?
Time Factors
1
2015
2152
0.080
Why?
Leucovorin
2
2019
25
0.080
Why?
Fluorouracil
2
2019
82
0.080
Why?
Cardiovascular Diseases
1
2015
1125
0.070
Why?
Diabetes Mellitus, Type 2
1
2015
1428
0.070
Why?
Macromolecular Substances
1
2003
17
0.060
Why?
Molecular Weight
1
2003
41
0.060
Why?
Saccharomyces cerevisiae
1
2003
20
0.060
Why?
Binding Sites
1
2003
130
0.050
Why?
DNA Breaks, Double-Stranded
2
2012
17
0.050
Why?
DNA-Binding Proteins
1
2003
147
0.050
Why?
DNA
1
2003
228
0.050
Why?
DNA Mutational Analysis
1
2020
72
0.050
Why?
Daunorubicin
1
2020
27
0.040
Why?
Disease-Free Survival
1
2020
319
0.040
Why?
Electron Transport Chain Complex Proteins
1
2019
8
0.040
Why?
Gene Knockout Techniques
1
2019
11
0.040
Why?
Membrane Potential, Mitochondrial
1
2019
17
0.040
Why?
Administration, Oral
1
2019
182
0.040
Why?
Mitochondrial Membranes
1
2019
21
0.040
Why?
Transduction, Genetic
1
2019
42
0.040
Why?
Sulfonamides
1
2019
67
0.040
Why?
Lymphopenia
1
2017
12
0.040
Why?
Hypokalemia
1
2017
14
0.040
Why?
Neutropenia
1
2017
30
0.040
Why?
Hypoalbuminemia
1
2017
12
0.040
Why?
Sensation Disorders
1
2017
20
0.040
Why?
Thrombocytopenia
1
2017
31
0.040
Why?
Maximum Tolerated Dose
1
2017
61
0.040
Why?
Camptothecin
1
2017
52
0.040
Why?
Organoplatinum Compounds
1
2017
47
0.040
Why?
Abdominal Pain
1
2017
45
0.040
Why?
Body Burden
1
2016
7
0.040
Why?
Astronauts
1
2016
8
0.040
Why?
Anemia
1
2017
59
0.040
Why?
Topotecan
1
2016
17
0.040
Why?
Radiation Dosage
1
2016
81
0.030
Why?
Liver
1
2019
483
0.030
Why?
Genome, Human
1
2016
132
0.030
Why?
Physical Examination
1
2016
92
0.030
Why?
Sepsis
1
2017
158
0.030
Why?
Mental Health
1
2016
115
0.030
Why?
Patient Discharge
1
2016
188
0.030
Why?
Diabetes Mellitus
1
2018
411
0.030
Why?
Survivors
1
2016
159
0.030
Why?
Mobility Limitation
1
2016
219
0.030
Why?
Logistic Models
1
2015
781
0.030
Why?
Affective Symptoms
1
2013
16
0.030
Why?
Leukemia, Monocytic, Acute
1
2012
2
0.030
Why?
Thymine
1
2012
6
0.030
Why?
S Phase
1
2012
15
0.030
Why?
Alkaloids
1
2012
9
0.030
Why?
Secondary Prevention
1
2013
63
0.030
Why?
Leukemia, Promyelocytic, Acute
1
2012
21
0.030
Why?
Nursing Assessment
1
2011
11
0.020
Why?
Multivariate Analysis
1
2013
687
0.020
Why?
Feasibility Studies
1
2011
292
0.020
Why?
Motor Activity
1
2013
325
0.020
Why?
Predictive Value of Tests
1
2013
878
0.020
Why?
Disability Evaluation
1
2011
240
0.020
Why?
Core Binding Factor Alpha 2 Subunit
1
2009
8
0.020
Why?
Genes, ras
1
2009
25
0.020
Why?
Oncogene Proteins, Fusion
1
2009
16
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2009
261
0.020
Why?
Gene Expression Profiling
1
2009
323
0.020
Why?
Genotype
1
2009
734
0.020
Why?
Cohort Studies
1
2011
1831
0.020
Why?
North Carolina
1
2011
1516
0.020
Why?
Pardee's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (244)
Explore
_
Co-Authors (32)
Explore
_
Similar People (49)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_